TABLE 1.
Biological function of potential biomarkers and related enzyme genes in ovarian cancer.
Metabolites | Log FC | CA125 + AUC | Gene | KM p-value | Poor survival | Pathway | Function |
---|---|---|---|---|---|---|---|
Carnosine | 0.65 | 0.884 | CNDP1 | < 0.001 | High | Histidine metabolism | Apoptosis |
20-COOH-LTE4 | −0.28 | 0.899 | LTC4S | 0.012 | High | Arachidonic acid metabolism | Angiogenesis |
Sebacic acid | 0.2 | 0.879 | ACADL | < 0.001 | Low | Fatty acid metabolism | Inhibit metastasis |
Calcitriol lactone | −0.66 | 0.963 | DHCR24 | 0.011 | Low | Steroid biosynthesis | Inhibit proliferation |
20a,22b-Dihydroxycholesterol | 0.3 | 0.88 | CYP11A1 | 0.046 | High | Steroid hormone biosynthesis | Proliferation |
Muricholic acid | −0.28 | 0.944 | CYP7A1 | 0.032 | High | bile acid biosynthesis | Proliferation drug resistance |
3,7,12,19-THCA | −0.47 | 0.935 | CYP27A1 | 0.01 | high | bile acid biosynthesis | Proliferation drug resistance |
Dihydrothymine | −0.48 | 0.88 | AGXT2 | 0.034 | low | Pyrimidine metabolism | Anti-apoptosis drug resistance |
Hexacosanoic acid | −0.14 | 0.926 | ACSL1 | 0.018 | low | Fatty acid metabolism | Proliferation drug |